Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-03-07 @ 9:04 AM
Study NCT ID:
NCT03638206
Status:
UNKNOWN
Last Update Posted:
2019-12-11
First Post:
2018-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Sponsor:
Shenzhen BinDeBio Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-cell Acute Lymphoblastic Leukemia | View |
| None | Lymphoma | View |
| None | Myeloid Leukemia | View |
| None | Multiple Myeloma | View |
| None | Hepatoma | View |
| None | Gastric Cancer | View |
| None | Pancreatic Cancer | View |
| None | Mesothelioma | View |
| None | Colorectal Cancer | View |
| None | Esophagus Cancer | View |
| None | Lung Cancer | View |
| None | Glioma | View |
| None | Melanoma | View |
| None | Synovial Sarcoma | View |
| None | Ovarian Cancer | View |
| None | Renal Carcinoma | View |
Keywords: